Premium
Long noncoding RNAs in autoimmune diseases
Author(s) -
Xu Fei,
Jin Lei,
Jin Yueling,
Nie Zhiyan,
Zheng Hong
Publication year - 2019
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.36562
Subject(s) - biology , computational biology , human genome , immune system , long non coding rna , autoimmune disease , human disease , human health , genome , rna , genetics , gene , medicine , antibody , environmental health
With the completion of the human genome project and further development of high‐throughput genomic technologies, interest in long noncoding RNAs (lncRNAs), which are defined as non‐protein‐coding RNAs at least 200 nucleotides in length, has strongly increased, and lncRNAs have become a major research direction. Increasing evidence demonstrates that lncRNAs are closely related to human growth and development and to disease occurrence via various mechanisms. lncRNAs also play crucial roles in the differentiation and activation of immune cells, and their relationships with human autoimmune diseases have received increasing attention. The development of biotechnology has led to the gradual discovery of many potential lncRNA functions. In this review, we discuss various lncRNAs that have been implicated in different human autoimmune diseases, focusing on their clinical applications as potential biomarkers and therapeutic targets in the pathologies of diverse human autoimmune diseases. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 468–475, 2019.